CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Polpharma Biologics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Predicting Outcome Of Treatment With An Anti- 4 7 Integrin AntibodyMILLENNIUM PHARMACEUTICALSFeb 7, 2025
Assay For Jc Virus AntibodiesBIOGEN MAMay 23, 2023
Method Of Assessing Risk Of PmlBIOGEN MADec 1, 2022
Methods For Treating Progressive Multiple SclerosisF HOFFMANN LA ROCHEJun 8, 2021
Methods For Evaluating An Immune Response To A Therapeutic AgentBIOGEN MAMay 18, 2021
Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabBIOGEN IDEC MAMay 14, 2020
Method Of Assessing Risk Of PmlBIOGEN IDEC MAJan 17, 2020

Top competitors of Polpharma Biologics

List of top competitors of Polpharma Biologics based on patent oppositions.